One GLP-1 drug cuts risk of worsening depression by 44% in major study

18 March 2026

Credit: Getty Images/coldsnowstorm

By Emma Wilkinson

Use of GLP1 medications to treat diabetes and obesity might prevent worsening of depression and anxiety, a large study has reported.

It is not the first time a link between the weight loss medications and mood disorders has been noted but the researchers said they were surprised by the magnitude of the effect they found.







Log in or join for free to read more

You might also like